HR
Hayden Royal’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | $280K | Sell |
3,693
-1,173
| -24% | -$88.9K | 0.66% | 53 |
|
2021
Q3 | $545K | Sell |
4,866
-34
| -0.7% | -$3.81K | 0.89% | 26 |
|
2021
Q2 | $793K | Buy |
4,900
+310
| +7% | +$50.2K | 0.44% | 65 |
|
2021
Q1 | $559K | Buy |
+4,590
| New | +$559K | 0.32% | 75 |
|
2020
Q4 | – | Sell |
-4,045
| Closed | -$338K | – | 485 |
|
2020
Q3 | $338K | Buy |
+4,045
| New | +$338K | 0.18% | 127 |
|